- Trials with a EudraCT protocol (383)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
383 result(s) found for: Contraindication.
Displaying page 1 of 20.
EudraCT Number: 2004-001236-23 | Sponsor Protocol Number: IMP 25300 | Start Date*: 2004-11-23 | |||||||||||
Sponsor Name:Serono International S.A. | |||||||||||||
Full Title: A multicentre, open label Phase IIIb/IV study of subcutaneously administered efalizumab in the treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respon... | |||||||||||||
Medical condition: Adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant of other systemic therapies including cyclosporin... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) CZ (Completed) DK (Completed) SE (Completed) ES (Completed) SK (Completed) AT (Completed) IE (Completed) IT (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001805-90 | Sponsor Protocol Number: 04TPNGLN01SP | Start Date*: 2005-12-15 |
Sponsor Name:Fresenius Kabi | ||
Full Title: Efficacy and security of glutamine dipeptide (Dipeptiven®) - Supplemented parenteral nutrition in critic patients. Double blind, randomized, multicenter study. | ||
Medical condition: Critic patient that require parenteral nutrition | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004243-29 | Sponsor Protocol Number: 27809 | Start Date*: 2008-05-23 | |||||||||||
Sponsor Name:Merck Serono International SA. An Affiliate of Merck KGaA, Darmstadt, Germany | |||||||||||||
Full Title: A Phase IV open label study in moderate to severe chronic plaque psoriasis subjects transitioning from previous systemic antipsoriasis therapies (methotrexate, cyclosporine, retinoids or PUVA, NBUV... | |||||||||||||
Medical condition: Adult subjects with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including cyclosporin... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003756-39 | Sponsor Protocol Number: RDEA594-303 | Start Date*: 2012-04-10 | |||||||||||
Sponsor Name:Ardea Biosciences, Inc. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects with Gout and an Intolerance or... | |||||||||||||
Medical condition: Gout | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000431-14 | Sponsor Protocol Number: M16-098 | Start Date*: 2017-11-13 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis | |||||||||||||
Medical condition: Active Ankylosing Spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DK (Completed) DE (Completed) FI (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) ES (Completed) PT (Completed) NL (Completed) BE (Completed) HU (Completed) PL (Completed) SE (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002175-28 | Sponsor Protocol Number: DACOMINT14 | Start Date*: 2014-08-04 | |||||||||||
Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | |||||||||||||
Full Title: Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication... | |||||||||||||
Medical condition: locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication to surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000267-26 | Sponsor Protocol Number: CF-FOS-COR-04 | Start Date*: 2006-01-12 |
Sponsor Name:LABORATORIOS CASEN-FLEET,S.L. | ||
Full Title: ESTUDIO COMPARATIVO DE EFICACIA Y SEGURIDAD DE FOSFOSODA R FRENTE A SOLUCIÓN EVACUANTE BOHM R COMO TRATAMIENTO EVACUANTE PREVIO A CIRUGÍA DIGESTIVA O EXPLORACIÓN COLÓNICA | ||
Medical condition: phase IV,observational, randomized, controled, blind, single center | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002654-79 | Sponsor Protocol Number: P160954J | Start Date*: 2019-02-13 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: TEMOTRAD 01 : First-line chemotherapy with temozolomide alone for non-enhancing adult brainstem gliomas, with a diffuse subtype and showing clinical and/or radiological infiltrative pattern of pro... | |||||||||||||
Medical condition: adult brainstem gliomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000043-31 | Sponsor Protocol Number: 383 | Start Date*: 2020-03-26 |
Sponsor Name:Groupe Hospitalier Paris Saint-Joseph | ||
Full Title: Efficacy and tolerance of Liraglutide for weight loss in obese type 2 diabetic hemodialysis patients | ||
Medical condition: obese type 2 diabetic hemodialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000080-85 | Sponsor Protocol Number: 17-245 | Start Date*: 2018-11-29 | |||||||||||
Sponsor Name:CHU CAEN | |||||||||||||
Full Title: Pilot study of the pharmacokinetic profile of paracetamol subcutaneously versus intravenously in patients receiving palliative care | |||||||||||||
Medical condition: Major patients in palliative care | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004600-19 | Sponsor Protocol Number: PAINTER01 | Start Date*: 2014-01-21 |
Sponsor Name:Azienda Ospedaliera Fatebenefratelli e Oftalmico - Milano, Italy | ||
Full Title: Multicenter, interventional, single-arm, phase IV study evaluating tolerability of Eribulin and its relationship with a set of polymorphisms in an unselected population of female patients with meta... | ||
Medical condition: Patients with metastatic breast cancer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018279-99 | Sponsor Protocol Number: HUM07-066 | Start Date*: 2010-05-05 |
Sponsor Name:Faculty of Medicine, Otto-von-Guericke-University Magdeburg | ||
Full Title: Skin Topoproteome under Adalimumab (Humira®) Treatment in Patients with Moderate to Severe Psoriasis | ||
Medical condition: Disease under investigation: Adult patients of both genders with moderate to severe chronic plaque psoriasis who failed to respond to or who have a contraindication to, or are intolerant to other s... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-014527-23 | Sponsor Protocol Number: MG-ECALTA1 | Start Date*: 2009-10-13 |
Sponsor Name:KH der Elisabethinen Linz GmbH, I. Interne Abteilung | ||
Full Title: Anidulafungin in patients with hematologic malignancies - An open-label, prospective study to evaluate the safety profile at prophylactic and therapeutic dosages | ||
Medical condition: hematologic malignancies with risk for or active invasive fungal infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000368-10 | Sponsor Protocol Number: NEX-426-MEI-0040-I | Start Date*: 2006-08-10 |
Sponsor Name:Tecnical University of Munich | ||
Full Title: High-dose therapy with Esomeprazol in combination with Baclofen therapy for symptomatic therapy-resistant gastrooesophageal reflux disease. | ||
Medical condition: Gastroesophageal reflux disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-020759-30 | Sponsor Protocol Number: [11C]inhibitors | Start Date*: 2010-11-03 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: A pilot study to assess [11C]elacridar and [11C]tariquidar as two positron emission tomography radiotracers for visualization of P-glycoprotein in humans. | ||
Medical condition: healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000773-60 | Sponsor Protocol Number: SNMC 301 | Start Date*: 2004-10-22 |
Sponsor Name:Healthcare & Pharma Consulting AG (Europe) | ||
Full Title: 52 week multicenter, randomized, double-blind placebo-controlled trial evaluating the efficacy and safety of SNMC in patients with chronic hepatitis C | ||
Medical condition: Chronic hepatitis C | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001630-14 | Sponsor Protocol Number: DRN0307 | Start Date*: 2007-10-30 | |||||||||||
Sponsor Name:University Medical Centre St. Radboud, Department of Dermatology | |||||||||||||
Full Title: Safety and efficacy of efalizumab in combination with methotrexate in patients with severe psoriasis: a comparative study. | |||||||||||||
Medical condition: Moderate to severe chronic plaque psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001155-40 | Sponsor Protocol Number: 16032020 | Start Date*: 2020-08-20 | ||||||||||||||||
Sponsor Name:Steno Diabetes Center Copenhagen | ||||||||||||||||||
Full Title: Kidney Fat in Type 2 Diabetes & Diabetic Kidney Disease and the Effects of Ezetimibe: A Cross-Sectional Study and Randomized, Placebo-Controlled Trial | ||||||||||||||||||
Medical condition: Type 2 diabetes, diabetic kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000614-39 | Sponsor Protocol Number: 2016/9408 | Start Date*: 2017-03-22 |
Sponsor Name:OSLO UNIVERSITY HOSPITAL HF | ||
Full Title: Prevention of graft-versus-host disease in patients treated with allogeneic stem cell transplantation: Possible role of extracorporeal photophoresis | ||
Medical condition: Graft-versus-host disease (GVHD), both acute and chronic untill one year after allogeneic stam cell transplatation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004697-25 | Sponsor Protocol Number: V528Nov22 | Start Date*: 2020-09-14 | |||||||||||
Sponsor Name:The Rotunda Hospital | |||||||||||||
Full Title: The Home Induction trial: A randomised open-label trial to assess outpatient induction of labour, and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks’ gestation in nor... | |||||||||||||
Medical condition: Normal risk nulliparous women who have no pregnancy-related or medical contraindication to Induction of Labour | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.